NL8101271A - Cefapirine-esters en -zouten alsmede werkwijze ter bereiding hiervan. - Google Patents
Cefapirine-esters en -zouten alsmede werkwijze ter bereiding hiervan. Download PDFInfo
- Publication number
- NL8101271A NL8101271A NL8101271A NL8101271A NL8101271A NL 8101271 A NL8101271 A NL 8101271A NL 8101271 A NL8101271 A NL 8101271A NL 8101271 A NL8101271 A NL 8101271A NL 8101271 A NL8101271 A NL 8101271A
- Authority
- NL
- Netherlands
- Prior art keywords
- cefapirin
- esters
- formula
- acid
- ester
- Prior art date
Links
- UQLLWWBDSUHNEB-CZUORRHYSA-N Cefaprin Chemical class N([C@H]1[C@@H]2N(C1=O)C(=C(CS2)COC(=O)C)C(O)=O)C(=O)CSC1=CC=NC=C1 UQLLWWBDSUHNEB-CZUORRHYSA-N 0.000 title claims description 30
- 238000000034 method Methods 0.000 title claims description 14
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 48
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 33
- 229960004350 cefapirin Drugs 0.000 claims description 27
- 150000002148 esters Chemical class 0.000 claims description 23
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims description 20
- -1 cefapirin compound Chemical class 0.000 claims description 16
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 claims description 15
- 150000003839 salts Chemical class 0.000 claims description 14
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical class CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 claims description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 9
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 claims description 8
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical compound NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 claims description 8
- CLMSHAWYULIVFQ-UHFFFAOYSA-N 3-bromo-3h-2-benzofuran-1-one Chemical compound C1=CC=C2C(Br)OC(=O)C2=C1 CLMSHAWYULIVFQ-UHFFFAOYSA-N 0.000 claims description 7
- 239000002253 acid Substances 0.000 claims description 7
- GGRHYQCXXYLUTL-UHFFFAOYSA-N chloromethyl 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCl GGRHYQCXXYLUTL-UHFFFAOYSA-N 0.000 claims description 7
- 150000001875 compounds Chemical class 0.000 claims description 7
- 239000002904 solvent Substances 0.000 claims description 7
- 238000002360 preparation method Methods 0.000 claims description 5
- 159000000000 sodium salts Chemical group 0.000 claims description 5
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000008020 evaporation Effects 0.000 claims description 2
- 239000003495 polar organic solvent Substances 0.000 claims description 2
- DMKDRSIXSDKEFQ-KDXMTYKHSA-N Cephaline Natural products CCCCCCCCCCCCCCCCCOC(=O)C[C@@H](COP(=O)(O)CCN)C(=O)OCCCCCCCC=CCCCCCCCC DMKDRSIXSDKEFQ-KDXMTYKHSA-N 0.000 claims 1
- 150000003973 alkyl amines Chemical class 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000005406 washing Methods 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 42
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 39
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 29
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 15
- 238000004809 thin layer chromatography Methods 0.000 description 14
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 12
- 239000012071 phase Substances 0.000 description 11
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 238000006243 chemical reaction Methods 0.000 description 8
- 239000003480 eluent Substances 0.000 description 8
- 239000003208 petroleum Substances 0.000 description 8
- 235000019253 formic acid Nutrition 0.000 description 7
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 7
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 7
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 7
- 230000002906 microbiologic effect Effects 0.000 description 7
- 239000011734 sodium Substances 0.000 description 7
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 6
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- WNZQDUSMALZDQF-UHFFFAOYSA-N isobenzofuranone Natural products C1=CC=C2C(=O)OCC2=C1 WNZQDUSMALZDQF-UHFFFAOYSA-N 0.000 description 6
- 229910052708 sodium Inorganic materials 0.000 description 6
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 5
- 230000002378 acidificating effect Effects 0.000 description 5
- 239000008346 aqueous phase Substances 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 description 4
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 description 4
- 239000000460 chlorine Substances 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 3
- NMKSBNZBSLHAKW-UHFFFAOYSA-N Cl.ClO Chemical compound Cl.ClO NMKSBNZBSLHAKW-UHFFFAOYSA-N 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000370 acceptor Substances 0.000 description 3
- 229910052801 chlorine Inorganic materials 0.000 description 3
- 238000007865 diluting Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 3
- 235000019341 magnesium sulphate Nutrition 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229940113088 dimethylacetamide Drugs 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 239000012074 organic phase Substances 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 229910052938 sodium sulfate Inorganic materials 0.000 description 2
- 235000011152 sodium sulphate Nutrition 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- UFWIBTONFRDIAS-UHFFFAOYSA-N Naphthalene Chemical compound C1=CC=CC2=CC=CC=C21 UFWIBTONFRDIAS-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 1
- KVBGVZZKJNLNJU-UHFFFAOYSA-N naphthalene-2-sulfonic acid Chemical compound C1=CC=CC2=CC(S(=O)(=O)O)=CC=C21 KVBGVZZKJNLNJU-UHFFFAOYSA-N 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Classifications
-
- H—ELECTRICITY
- H01—ELECTRIC ELEMENTS
- H01H—ELECTRIC SWITCHES; RELAYS; SELECTORS; EMERGENCY PROTECTIVE DEVICES
- H01H27/00—Switches operated by a removable member, e.g. key, plug or plate; Switches operated by setting members according to a single predetermined combination out of several possible settings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/26—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
- C07D501/34—Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT20666/80A IT1130969B (it) | 1980-03-14 | 1980-03-14 | Esteri della cefapirina,loro sali e procedimento per il loro ottenimento |
| IT2066680 | 1980-03-14 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NL8101271A true NL8101271A (nl) | 1981-10-01 |
Family
ID=11170271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8101271A NL8101271A (nl) | 1980-03-14 | 1981-03-16 | Cefapirine-esters en -zouten alsmede werkwijze ter bereiding hiervan. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US4393205A (ref) |
| JP (1) | JPS56133295A (ref) |
| KR (2) | KR840002045B1 (ref) |
| CA (1) | CA1133470A (ref) |
| CH (1) | CH652722A5 (ref) |
| DE (1) | DE3108237A1 (ref) |
| FR (1) | FR2478103A1 (ref) |
| GB (1) | GB2071659B (ref) |
| IL (1) | IL62253A (ref) |
| IT (1) | IT1130969B (ref) |
| NL (1) | NL8101271A (ref) |
| YU (1) | YU63081A (ref) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3422100A (en) * | 1967-05-02 | 1969-01-14 | Bristol Myers Co | S-substituted-thioacetamido-cephalosporins |
| FR2020209A1 (en) * | 1968-10-09 | 1970-07-10 | Sarath | Antibiotic acylxymethyl 7-(alpha-amino-alpha-phenyl- - acetamido)-3-methyl-delta-3-cephem-4-carboxylates |
| US3578661A (en) * | 1969-06-02 | 1971-05-11 | Bristol Myers Co | Process for the preparation of 7-(alpha-(4 - pyridylthio)acetamido)cephalosporanic acids |
| GB1355804A (en) * | 1970-12-04 | 1974-06-05 | Beecham Group Ltd | Penicillins and cephalosporinesters |
| GB1364672A (en) * | 1971-06-09 | 1974-08-29 | Beecham Group Ltd | Penicillins |
| GB1492393A (en) * | 1974-02-21 | 1977-11-16 | Beecham Group Ltd | Cephalosporin esters |
-
1980
- 1980-03-14 IT IT20666/80A patent/IT1130969B/it active
-
1981
- 1981-03-02 IL IL62253A patent/IL62253A/xx unknown
- 1981-03-05 US US06/240,945 patent/US4393205A/en not_active Expired - Fee Related
- 1981-03-05 DE DE19813108237 patent/DE3108237A1/de not_active Withdrawn
- 1981-03-09 CH CH1585/81A patent/CH652722A5/it not_active IP Right Cessation
- 1981-03-10 GB GB8107529A patent/GB2071659B/en not_active Expired
- 1981-03-10 FR FR8104702A patent/FR2478103A1/fr active Granted
- 1981-03-12 JP JP3467481A patent/JPS56133295A/ja active Granted
- 1981-03-12 YU YU00630/81A patent/YU63081A/xx unknown
- 1981-03-13 CA CA372,958A patent/CA1133470A/en not_active Expired
- 1981-03-14 KR KR1019810000832A patent/KR840002045B1/ko not_active Expired
- 1981-03-16 NL NL8101271A patent/NL8101271A/nl not_active Application Discontinuation
-
1984
- 1984-06-21 KR KR1019840003507A patent/KR840002044B1/ko not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| IT8020666A0 (it) | 1980-03-14 |
| FR2478103B1 (ref) | 1985-01-04 |
| JPS56133295A (en) | 1981-10-19 |
| FR2478103A1 (fr) | 1981-09-18 |
| CA1133470A (en) | 1982-10-12 |
| KR840002045B1 (ko) | 1984-11-06 |
| KR840002044B1 (ko) | 1984-11-06 |
| DE3108237A1 (de) | 1982-04-01 |
| CH652722A5 (it) | 1985-11-29 |
| US4393205A (en) | 1983-07-12 |
| IL62253A (en) | 1984-09-30 |
| YU63081A (en) | 1983-10-31 |
| IL62253A0 (en) | 1981-05-20 |
| IT1130969B (it) | 1986-06-18 |
| GB2071659B (en) | 1983-11-09 |
| JPH0161117B2 (ref) | 1989-12-27 |
| KR850000179A (ko) | 1985-02-25 |
| KR830005243A (ko) | 1983-08-03 |
| GB2071659A (en) | 1981-09-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2607813A1 (fr) | Alkylamino-8 imidazo (1,2-a) pyrazines et derives, leur preparation et leur application en therapeutique | |
| CA2104883A1 (fr) | Derives d'acide thienyl ou pyrrolyl carboxyliques, leur preparation et medicaments les contenant | |
| US12157744B2 (en) | Compounds and methods of their manufacturing | |
| EP0379412B1 (fr) | Dérivés de benzonaphtyridine-1,8 leur préparation et les compositions qui les contiennent | |
| LU83609A1 (fr) | Procede de preparation de derives d'acides quinoleine-carboxyliques | |
| CZ20013658A3 (cs) | Syntéza a krystalizace sloučenin obsahujících piperazinový kruh | |
| EP0763043A1 (fr) | Procede pour la preparation du cefixime trihydrate | |
| FR2496666A1 (fr) | Nouveaux derives de cephalosporine et composition pharmaceutique les contenant | |
| NL8101271A (nl) | Cefapirine-esters en -zouten alsmede werkwijze ter bereiding hiervan. | |
| IL28645A (en) | Tropine derivatives | |
| KR100235375B1 (ko) | 2-아미노나프티리딘 유도체의 광학 이성질체 제조 방법 | |
| KR100235376B1 (ko) | 2-아미노나프티리딘 유도체 그의 제조 방법 | |
| MC1195A1 (fr) | Derives acyles | |
| CA1040205A (en) | Process for the racemate splitting of d,l-penicillamine | |
| US4180660A (en) | Cephalosporin derivatives | |
| US4122260A (en) | Cephalosporin derivatives | |
| US4060527A (en) | Pyrido[2,3-c]-acridine-1-hydroxy-2-carboxylic acid derivatives | |
| JPH078853B2 (ja) | ドーパミン誘導体の製法 | |
| JPH03279348A (ja) | ２，４，５―トリフルオロ―３―アルコキシ安息香酸の製造方法 | |
| FI59595B (fi) | Foerfarande foer framstaellning av terapeutiskt anvaendbara 5 eller 6-trifluormetyl 3-(4-alkylpiperazin-1-yl)karbonyloxi-2-(1,8-naftyridin-2-yl)isoindolin-1-oner | |
| HUT58734A (en) | Optical separating process for producing 3r/3-carboxy-benzyl/-6-/5-fluoro-2-benzothiazolyl/-methoxy-4r-chromanol | |
| US4200747A (en) | 7-2-Indolyl acetamido cephalosporin derivatives | |
| KR840000501B1 (ko) | 세팔로스포린 데스아세톡시 에스테르의 제조방법 | |
| US4375543A (en) | N-[3-(1'-3"-Oxapentamethylene-amino-ethylideneamino)-2,4,6-triiodobenzoyl]-β-amino-α- methylpropionitrile in process to make corresponding acid | |
| US4229574A (en) | Indole cephalosporin derivatives |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A85 | Still pending on 85-01-01 | ||
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| BV | The patent application has lapsed |